Arch Therapeutics Inc (ARTH)

[Polyphemus]

I am new to this board & this type of trading. I have a few questions:

Do the company fundamentals matter in this type of situation? For example, looking at the 10K, I note that the CEO received over $447K in cash comp and another $800K in stock & options. Also, it appears that he has never actually led a company that has commercialized a significant product. Finally, the first product is a topical wound care product, which would play in a tough, price sensitive market. So for success, does one play the short term trading moves & press releases onlky/primarily, or does on bet on the commercialization results of the first product (6 - 9 months in the future). Please provide your thoughts.